Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-Related Macular Degeneration (ARMD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04747197
What this trial is testing

First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
EyePoint Pharmaceuticals, Inc. 17
Not applicableStudy completedNCT03024424
What this trial is testing

Value of Genetic Counseling and Testing for Patients Who Would Like to Know More About Their Personal Risk of AMD

Who this might be right for
Age-Related Macular DegenerationChoroidal NeovascularizationGenetic Counseling
University of Utah 16
Not applicableStudy completedNCT01464710
What this trial is testing

Genetic Assessment of Early to Late Macular Degeneration Study

Who this might be right for
Age-related Macular Degeneration
Henry Ferreyra 170
Not applicableStudy completedNCT00348543
What this trial is testing

Prophylactic Laser Treatment of Drusen Maculopathy

Who this might be right for
Age-related Macular Degeneration
University Hospital, Linkoeping 150
Testing effectiveness (Phase 2)Study completedNCT01982435
What this trial is testing

Safety and Efficacy of Ranibizumab for Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Justis Ehlers 27
Not applicableStudy completedNCT04891835
What this trial is testing

Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in "Treat-and-extend" at CHU Brugmann

Who this might be right for
Age-related Macular Degeneration
Laurence Postelmans 36
Not applicableStudy completedNCT01258335
What this trial is testing

Omega-3-fatty Acids on Age-related Macular

Who this might be right for
Aged Macular Degeneration
Mid Atlantic Retina 25
Not applicableEnded earlyNCT01410201
What this trial is testing

Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane

Who this might be right for
Epiretinal MembraneMacular Edema
Barnes Retina Institute 6
Not applicableUnknownNCT05752045
What this trial is testing

OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaAge-Related Macular Degeneration+2 more
Evolucare Technologies 1,389
Testing effectiveness (Phase 2)Study completedNCT04640272
What this trial is testing

A Multi-Center, Open Label, Extension Study Assessing the Efficacy and Safety of Additional Intravitreal Injections of RBM-007 in Subjects With Wet Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Ribomic USA Inc 40
Not applicableNot Yet RecruitingNCT07265895
What this trial is testing

Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations

Who this might be right for
Retinal DegenerationsRetinitis Pigmentosa (RP)Stargardt Disease
IRCCS San Raffaele 200
Not applicableStudy completedNCT03751501
What this trial is testing

Targeted Laser in Diabetic Macular Edema

Who this might be right for
Macular EdemaDiabetic Retinopathy
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 270
Large-scale testing (Phase 3)WithdrawnNCT00406172
What this trial is testing

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

Who this might be right for
Cystoid Macular Edema
Asociación para Evitar la Ceguera en México
Not applicableStudy completedNCT05135195
What this trial is testing

A Virtual Reality Platform Simulating Visual Impairment for Testing of Electronic Travel Aids and Performing Orientation and Mobility Training

Who this might be right for
Visual ImpairmentAge-Related Macular DegenerationDiabetic Retinopathy+1 more
NYU Langone Health 98
Testing effectiveness (Phase 2)Study completedNCT01030601
What this trial is testing

Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS)

Who this might be right for
DiabetesMacular EdemaPseudophakia
University Health Network, Toronto 48
Large-scale testing (Phase 3)Active Not RecruitingNCT06856577
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 311
Post-approval studies (Phase 4)Ended earlyNCT00134667
What this trial is testing

Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Eyetech Pharmaceuticals 360
Early research (Phase 1)Temporarily pausedNCT00541333
What this trial is testing

Weekly Vaccination With Copaxone as a Potential Therapy for Dry Age-related Macular Degeneration

Who this might be right for
Dry Age Related Macular Degeneration
The New York Eye & Ear Infirmary 15
Not applicableEnded earlyNCT03935126
What this trial is testing

Global Atrophie Biomarker Evaluation Study (GABiE)

Who this might be right for
Age-related Macular Degeneration
Boehringer Ingelheim 3
Testing effectiveness (Phase 2)Ended earlyNCT02222207
What this trial is testing

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

Who this might be right for
Macular Degeneration
Bayer 52
Next Page